Copyright Reports & Markets. All rights reserved.

Global Pituitary cancer Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Pituitary cancer Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Blood Tests
      • 1.4.3 Urine Test
      • 1.4.4 Brain Imaging
      • 1.4.5 Vision Testing
    • 1.5 Market by Application
      • 1.5.1 Global Pituitary cancer Market Share by Application (2014-2025)
      • 1.5.2 Hospital
      • 1.5.3 Clinics
      • 1.5.4 Diagnostic Centers
      • 1.5.5 Research Institutes
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Pituitary cancer Market Size
    • 2.2 Pituitary cancer Growth Trends by Regions
      • 2.2.1 Pituitary cancer Market Size by Regions (2014-2025)
      • 2.2.2 Pituitary cancer Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Pituitary cancer Market Size by Manufacturers
      • 3.1.1 Global Pituitary cancer Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Pituitary cancer Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Pituitary cancer Market Concentration Ratio (CR5 and HHI)
    • 3.2 Pituitary cancer Key Players Head office and Area Served
    • 3.3 Key Players Pituitary cancer Product/Solution/Service
    • 3.4 Date of Enter into Pituitary cancer Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Pituitary cancer Market Size by Type (2014-2019)
    • 4.2 Global Pituitary cancer Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Pituitary cancer Market Size (2014-2019)
    • 5.2 Pituitary cancer Key Players in United States
    • 5.3 United States Pituitary cancer Market Size by Type
    • 5.4 United States Pituitary cancer Market Size by Application

    6 Europe

    • 6.1 Europe Pituitary cancer Market Size (2014-2019)
    • 6.2 Pituitary cancer Key Players in Europe
    • 6.3 Europe Pituitary cancer Market Size by Type
    • 6.4 Europe Pituitary cancer Market Size by Application

    7 China

    • 7.1 China Pituitary cancer Market Size (2014-2019)
    • 7.2 Pituitary cancer Key Players in China
    • 7.3 China Pituitary cancer Market Size by Type
    • 7.4 China Pituitary cancer Market Size by Application

    8 Japan

    • 8.1 Japan Pituitary cancer Market Size (2014-2019)
    • 8.2 Pituitary cancer Key Players in Japan
    • 8.3 Japan Pituitary cancer Market Size by Type
    • 8.4 Japan Pituitary cancer Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Pituitary cancer Market Size (2014-2019)
    • 9.2 Pituitary cancer Key Players in Southeast Asia
    • 9.3 Southeast Asia Pituitary cancer Market Size by Type
    • 9.4 Southeast Asia Pituitary cancer Market Size by Application

    10 India

    • 10.1 India Pituitary cancer Market Size (2014-2019)
    • 10.2 Pituitary cancer Key Players in India
    • 10.3 India Pituitary cancer Market Size by Type
    • 10.4 India Pituitary cancer Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Pituitary cancer Market Size (2014-2019)
    • 11.2 Pituitary cancer Key Players in Central & South America
    • 11.3 Central & South America Pituitary cancer Market Size by Type
    • 11.4 Central & South America Pituitary cancer Market Size by Application

    12 International Players Profiles

    • 12.1 Trinity Biotech
      • 12.1.1 Trinity Biotech Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Pituitary cancer Introduction
      • 12.1.4 Trinity Biotech Revenue in Pituitary cancer Business (2014-2019)
      • 12.1.5 Trinity Biotech Recent Development
    • 12.2 Salzman
      • 12.2.1 Salzman Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Pituitary cancer Introduction
      • 12.2.4 Salzman Revenue in Pituitary cancer Business (2014-2019)
      • 12.2.5 Salzman Recent Development
    • 12.3 Genentech
      • 12.3.1 Genentech Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Pituitary cancer Introduction
      • 12.3.4 Genentech Revenue in Pituitary cancer Business (2014-2019)
      • 12.3.5 Genentech Recent Development
    • 12.4 Sigma-Aldrich
      • 12.4.1 Sigma-Aldrich Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Pituitary cancer Introduction
      • 12.4.4 Sigma-Aldrich Revenue in Pituitary cancer Business (2014-2019)
      • 12.4.5 Sigma-Aldrich Recent Development
    • 12.5 Varian Medical Systems
      • 12.5.1 Varian Medical Systems Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Pituitary cancer Introduction
      • 12.5.4 Varian Medical Systems Revenue in Pituitary cancer Business (2014-2019)
      • 12.5.5 Varian Medical Systems Recent Development
    • 12.6 Elekta
      • 12.6.1 Elekta Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Pituitary cancer Introduction
      • 12.6.4 Elekta Revenue in Pituitary cancer Business (2014-2019)
      • 12.6.5 Elekta Recent Development
    • 12.7 Accuray Incorporated
      • 12.7.1 Accuray Incorporated Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Pituitary cancer Introduction
      • 12.7.4 Accuray Incorporated Revenue in Pituitary cancer Business (2014-2019)
      • 12.7.5 Accuray Incorporated Recent Development
    • 12.8 Ion Beam Applications
      • 12.8.1 Ion Beam Applications Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Pituitary cancer Introduction
      • 12.8.4 Ion Beam Applications Revenue in Pituitary cancer Business (2014-2019)
      • 12.8.5 Ion Beam Applications Recent Development
    • 12.9 Nordion
      • 12.9.1 Nordion Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Pituitary cancer Introduction
      • 12.9.4 Nordion Revenue in Pituitary cancer Business (2014-2019)
      • 12.9.5 Nordion Recent Development
    • 12.10 C. R. Bard
      • 12.10.1 C. R. Bard Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Pituitary cancer Introduction
      • 12.10.4 C. R. Bard Revenue in Pituitary cancer Business (2014-2019)
      • 12.10.5 C. R. Bard Recent Development
    • 12.11 Isoray Medical
    • 12.12 RaySearch Laboratories
    • 12.13 Mevion Medical Systems
    • 12.14 Mitsubishi Electric

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Pituitary adenomas are tumors that occur in the pituitary gland. Pituitary adenomas are generally divided into three categories dependent upon their biological functioning: benign adenoma, invasive adenoma, and carcinomas. Most adenomas are benign, approximately 35% are invasive and just 0.1% to 0.2% are carcinomas. Pituitary adenomas represent from 10% to 25% of all intracranial neoplasms and the estimated prevalence rate in the general population is approximately 17%.
      While pituitary adenomas are common, affecting approximately one in 6 of the general population, clinically active pituitary adenomas that require surgical treatment are more rare, affecting approximately one in 1000 of the general population.
      In 2018, the global Pituitary cancer market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Pituitary cancer status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pituitary cancer development in United States, Europe and China.

      The key players covered in this study
      Trinity Biotech
      Salzman
      Genentech
      Sigma-Aldrich
      Varian Medical Systems
      Elekta
      Accuray Incorporated
      Ion Beam Applications
      Nordion
      C. R. Bard
      Isoray Medical
      RaySearch Laboratories
      Mevion Medical Systems
      Mitsubishi Electric

      Market segment by Type, the product can be split into
      Blood Tests
      Urine Test
      Brain Imaging
      Vision Testing

      Market segment by Application, split into
      Hospital
      Clinics
      Diagnostic Centers
      Research Institutes

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Pituitary cancer status, future forecast, growth opportunity, key market and key players.
      To present the Pituitary cancer development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Pituitary cancer are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now